Original Contributions |
From the Department of Pharmacology, Hamamatsu University School of Medicine, Hamamatsu (S.K., K.U., K.K., M.N.), and Japan Immunoresearch Laboratories, Takasaki (A.R.S.), Japan.
Correspondence to Kazuo Umemura, MD, PhD, Department of Pharmacology, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu, 431-31, Japan. E-mail umemura{at}hama-med.ac.jp
AbstractWe have established a mouse
model of intimal thickening and assessed its suitability for
experimental studies of intimal thickening. Neointimal
formation was observed after endothelial injury by
photochemical reaction between transluminal green light and
systemically administered rose Bengal, which represents a
nonmechanical approach to vessel wall denudation. Intimal thickening
began 7 days after endothelial injury, reached a
maximum after 21 days, and then remained unchanged for as long as 42
days. Furthermore, as a consequence of neointimal
proliferation, the luminal area gradually decreased. The cells in the
neointimal layer were identified as smooth muscle cells by
immunohistochemical staining with an
-actinspecific antibody.
Extracellular matrix deposition in the neointima was
markedly increased beyond 14 days after injury. Smooth muscle cell
proliferation, as measured by pulse labeling of
5-bromo-2'-deoxyuridine, was identified initially in the media 2 days
after vessel wall denudation, with the proliferative activity's
shifting almost exclusively to the neointima within 7 days.
Endothelial regeneration, as indicated by Evans blue
staining, was complete within 21 days after injury. To assess the
suitability of this model for experimental studies on intimal
thickening, the effect of tranilast, an antiallergy drug with a broad
spectrum of pharmacological actions on intimal thickening, was
investigated. Tranilast (100 mg · kg-1 ·
d-1 PO) significantly (P<0.05) reduced
smooth muscle cell proliferation in the neointima and media
7 days after injury and neointimal formation 21 days after
injury in treated mice compared with vehicle-treated mice. This simple
experimental mouse model is suitable for studying factors promoting or
inhibiting intimal thickening after endothelial injury
and for developing therapeutic strategies against intimal
thickening.
Key Words: mouse endothelial injury intimal thickening smooth muscle cell proliferation tranilast
This article has been cited by other articles:
![]() |
S. Momi, E. Falcinelli, S. Giannini, L. Ruggeri, L. Cecchetti, T. Corazzi, C. Libert, and P. Gresele Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo J. Exp. Med., October 26, 2009; 206(11): 2365 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hirao, K. Kondo, K. Takeuchi, N. Inui, K. Umemura, K. Ohashi, and H. Watanabe Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries Cardiovasc Res, July 1, 2008; 79(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J.H. Sachs and B. Nieswandt In Vivo Thrombus Formation in Murine Models Circ. Res., April 13, 2007; 100(7): 979 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Denis and D. D. Wagner Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 728 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Goldenberg-Cohen, Y. Guo, F. Margolis, Y. Cohen, N. R. Miller, and S. L. Bernstein Oligodendrocyte Dysfunction after Induction of Experimental Anterior Optic Nerve Ischemia Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2716 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobayashi, K. Yokote, M. Fujimoto, K. Yamashita, A. Sakamoto, M. Kitahara, H. Kawamura, Y. Maezawa, S. Asaumi, T. Tokuhisa, et al. Targeted Disruption of TGF-{beta}-Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury Circ. Res., April 29, 2005; 96(8): 904 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. von der Thusen, M. L. Fekkes, R. Passier, A.J. van Zonneveld, V. Mainfroid, T. J.C. van Berkel, and E. A.L. Biessen Adenoviral Transfer of Endothelial Nitric Oxide Synthase Attenuates Lesion Formation in a Novel Murine Model of Postangioplasty Restenosis Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 357 - 362. [Abstract] [Full Text] |
||||
![]() |
S. L. Bernstein, Y. Guo, S. E. Kelman, R. W. Flower, and M. A. Johnson Functional and Cellular Responses in a Novel Rodent Model of Anterior Ischemic Optic Neuropathy Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4153 - 4162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shime, M. Kariya, A. Orii, C. Momma, T. Kanamori, K. Fukuhara, T. Kusakari, Y. Tsuruta, K. Takakura, T. Nikaido, et al. Tranilast Inhibits the Proliferation of Uterine Leiomyoma Cells in Vitro through G1 Arrest Associated with the Induction of p21waf1 and p53 J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5610 - 5617. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shintani, Y. Sawa, T. Takahashi, G. Matsumiya, N. Matsuura, Y. Miyamoto, and H. Matsuda Intraoperative transfection of vein grafts with the NF{kappa}B decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia Ann. Thorac. Surg., October 1, 2002; 74(4): 1132 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schafer, S. Konstantinides, C. Riedel, T. Thinnes, K. Muller, C. Dellas, G. Hasenfuss, and D. J. Loskutoff Different Mechanisms of Increased Luminal Stenosis After Arterial Injury in Mice Deficient for Urokinase- or Tissue-Type Plasminogen Activator Circulation, October 1, 2002; 106(14): 1847 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsuda, Y. Suzuki, K. Kondo, Y. Ikeda, and K. Umemura Hypercholesterolemia induces regression in neointimal thickening due to apoptosis of vascular smooth muscle cells in the hamster endothelial injury model Cardiovasc Res, February 1, 2002; 53(2): 512 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Izawa, J.-i. Suzuki, W. Takahashi, J. Amano, and M. Isobe Tranilast Inhibits Cardiac Allograft Vasculopathy in Association With p21Waf1/Cip1 Expression on Neointimal Cells in Murine Cardiac Transplantation Model Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1172 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Konstantinides, K. Schafer, T. Thinnes, and D. J. Loskutoff Plasminogen Activator Inhibitor-1 and Its Cofactor Vitronectin Stabilize Arterial Thrombi After Vascular Injury in Mice Circulation, January 30, 2001; 103(4): 576 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishiwata, S. Verheye, K. A. Robinson, M. Y. Salame, H. de Leon, S. B. King III, and N. A. F. Chronos Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1331 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Eitzman, R. J. Westrick, E. G. Nabel, and D. Ginsburg Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice Blood, January 15, 2000; 95(2): 577 - 580. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |